Literature DB >> 25500725

Deep sequencing of RYR3 gene identifies rare and common variants associated with increased carotid intima-media thickness (cIMT) in HIV-infected individuals.

Degui Zhi1, Aditi Shendre2, Rebecca Scherzer3, Marguerite R Irvin2, Rodney T Perry2, Shawn Levy4, Donna K Arnett2, Carl Grunfeld3, Sadeep Shrestha2.   

Abstract

Carotid intima-media thickness (cIMT) is a subclinical measure of atherosclerosis with mounting evidence that higher cIMT confers an increased risk of cardiovascular disease. The ryanodine receptor 3 gene (RYR3) has previously been linked to increased cIMT; however, the causal variants have not yet been localized. Therefore, we sequenced 339,480 bp encompassing 104 exons and 2 kb flanking region of the RYR3 gene in 96 HIV-positive white men from the extremes of the distribution of common cIMT from the Fat Redistribution and Metabolic Changes in HIV infection study (FRAM). We identified 2710 confirmed variants (2414 single-nucleotide polymorphisms (SNPs) and 296 insertion/deletions (indels)), with a mean count of 736 SNPs (ranging from 528 to 1032) and 170 indels (ranging from 128 to 214) distributed in each individual. There were 39 variants in the exons and 15 of these were non-synonymous, of which with only 4 were common variants and the remaining 11 were rare variants, one was a novel SNP. We confirmed that the common variant rs2229116 was significantly associated with cIMT in this design (P<7.9 × 10(-9)), and observed seven other significantly associated SNPs (P<10(-8)). These variants including the private non-synonymous SNPs need to be followed up in a larger sample size and also tested with clinical atherosclerotic outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25500725      PMCID: PMC6496937          DOI: 10.1038/jhg.2014.104

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  28 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Replication of RYR3 gene polymorphism association with cIMT among HIV-infected whites.

Authors:  Sadeep Shrestha; Qi Yan; Gregory Joseph; Donna K Arnett; Jeremy J Martinson; Lawrence A Kingsley
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

3.  Heritability of carotid artery structure and function: the Strong Heart Family Study.

Authors:  Kari E North; Jean W MacCluer; Richard B Devereux; Barbara V Howard; Thomas K Welty; Lyle G Best; Elisa T Lee; Richard R Fabsitz; Mary J Roman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

4.  A genome-wide association study of carotid atherosclerosis in HIV-infected men.

Authors:  Sadeep Shrestha; Marguerite R Irvin; Kent D Taylor; Howard W Wiener; Nicholas M Pajewski; Talin Haritunians; Joseph A C Delaney; Morris Schambelan; Joseph F Polak; Donna K Arnett; Yii-Der Ida Chen; Carl Grunfeld
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

5.  Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study.

Authors:  Caroline S Fox; Joseph F Polak; Irmarie Chazaro; Adrienne Cupples; Philip A Wolf; Ralph A D'Agostino; Christopher J O'Donnell
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

6.  Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; S K Wolfson; M G Bond; W Bommer; S Sheth; B M Psaty; A R Sharrett; T A Manolio
Journal:  Stroke       Date:  1991-09       Impact factor: 7.914

7.  The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.

Authors:  Phyllis C Tien; Constance Benson; Andrew R Zolopa; Stephen Sidney; Dennis Osmond; Carl Grunfeld
Journal:  Am J Epidemiol       Date:  2006-03-08       Impact factor: 4.897

8.  RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.

Authors:  A I Lynch; M R Irvin; E Boerwinkle; B R Davis; L K Vaughan; C E Ford; B Aissani; J H Eckfeldt; D K Arnett; S Shrestha
Journal:  Pharmacogenomics J       Date:  2012-06-05       Impact factor: 3.550

Review 9.  Innate immune recognition and activation during HIV infection.

Authors:  Trine H Mogensen; Jesper Melchjorsen; Carsten S Larsen; Søren R Paludan
Journal:  Retrovirology       Date:  2010-06-22       Impact factor: 4.602

10.  Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.

Authors:  Andreas Gnirke; Alexandre Melnikov; Jared Maguire; Peter Rogov; Emily M LeProust; William Brockman; Timothy Fennell; Georgia Giannoukos; Sheila Fisher; Carsten Russ; Stacey Gabriel; David B Jaffe; Eric S Lander; Chad Nusbaum
Journal:  Nat Biotechnol       Date:  2009-02-01       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.